Literature DB >> 2167278

Increased amino acid clearance and urea synthesis in a patient with glucagonoma.

T P Almdal1, H Heindorff, L Bardram, H Vilstrup.   

Abstract

Fasting concentrations, clearance of exogenous infused amino acids, and lean body mass were studied in a patient with glucagonoma syndrome (fasting glucagon = 380 pmol/l, normal range 15-45 pmol). The fasting concentrations of all amino acids were reduced. The clearances of alanine, arginine, glycine, isoleucine, leucine, lysine, methionine, proline, serine, threonine, and tyrosine were increased. The urea synthesis rate during amino acid infusion was 27 mumols/kg per minute (normal range 20-24 mumols/kg per minute). The lean body mass of the patients was reduced to 59% of the expected value. It is suggested that the weight loss of patients with glucagonoma syndrome is partly due to increased hepatic conversion of amino acid nitrogen to urea nitrogen, resulting in decreased blood amino acid concentration, and secondary to this, organ protein catabolism, as shown by the decreased lean body mass.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167278      PMCID: PMC1378630          DOI: 10.1136/gut.31.8.946

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

2.  Urinary creatinine excretion and lean body mass.

Authors:  G B Forbes; G J Bruining
Journal:  Am J Clin Nutr       Date:  1976-12       Impact factor: 7.045

3.  Effects of glucagon on amino acid transport and utilization in the perfused rat liver.

Authors:  L E Mallette; J H Exton
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

4.  A glucagonoma syndrome.

Authors:  C N Mallinson; S R Bloom; A P Warin; P R Salmon; B Cox
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

5.  Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

6.  Radioimmunological determination of pancreatic and gut glucagon in plasma.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1971-02       Impact factor: 10.122

7.  Effects of glucagon on plasma amino acids.

Authors:  G Boden; I Rezvani; O E Owen
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Free amino acid levels in muscle and liver of a patient with glucagonoma syndrome.

Authors:  E Roth; F Mühlbacher; J Karner; G Hamilton; J Funovics
Journal:  Metabolism       Date:  1987-01       Impact factor: 8.694

9.  Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis.

Authors:  B A Hansen; H Vilstrup
Journal:  Scand J Gastroenterol       Date:  1985-04       Impact factor: 2.423

10.  The effects of glucagon on protein metabolism in normal man.

Authors:  B M Wolfe; J M Culebras; T T Aoki; N E O'Connor; R J Finley; A Kaczowka; F D Moore
Journal:  Surgery       Date:  1979-08       Impact factor: 3.982

View more
  6 in total

1.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

2.  Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.

Authors:  Nicolai J Wewer Albrechtsen; Kristine Færch; Troels M Jensen; Daniel R Witte; Jens Pedersen; Yuvaraj Mahendran; Anna E Jonsson; Katrine D Galsgaard; Marie Winther-Sørensen; Signe S Torekov; Torsten Lauritzen; Oluf Pedersen; Filip K Knop; Torben Hansen; Marit E Jørgensen; Dorte Vistisen; Jens J Holst
Journal:  Diabetologia       Date:  2018-01-05       Impact factor: 10.122

3.  Effect of a LoBAG30 diet on protein metabolism in men with type 2 diabetes. A Randomized Controlled Trial.

Authors:  Frank Q Nuttall; Mary C Gannon
Journal:  Nutr Metab (Lond)       Date:  2012-05-20       Impact factor: 4.169

4.  Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.

Authors:  Young Lee; May-Yun Wang; Xiu Quan Du; Maureen J Charron; Roger H Unger
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

Review 5.  Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses.

Authors:  Carlos R Ferreira; Diego Martinelli; Nenad Blau
Journal:  Mol Genet Metab       Date:  2021-07-21       Impact factor: 4.204

6.  Clinical features and amino acid profiles of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.

Authors:  John P Loftus; Sharon A Center; Michael Astor; Adam J Miller; Jeanine Peters-Kennedy
Journal:  J Vet Intern Med       Date:  2021-09-02       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.